You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

PSMA

Showing 1 - 25 of 571
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prostate Cancer Trial in Beijing (Al18F-PSMA-617, 68Ga-PSMA-617)

Recruiting
  • Prostate Cancer
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
May 2, 2023

Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8 Trial in Seattle

Not yet recruiting
  • Castration-Resistant Prostate Carcinoma
  • +2 more
  • Biopsy
  • +9 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Nov 17, 2023

Prostate-Specific Membrane Antigen (PSMA) Radionuclide Therapy

Recruiting
  • PSMA-positive Metastatic Castration-resistant Prostate Cancer Treated With PSMA Radionuclide Therapy
  • PSMA radionuclide therapy
  • Dallas, Texas
    Methodist Dallas Medical Center
Aug 9, 2023

Prostate Cancer Trial in Nanjing (68Ga-PSMA-33)

Recruiting
  • Prostate Cancer
  • Nanjing, Jiangsu, China
    68Ga-PSMA-33 PET/CT imaging
Sep 19, 2023

Prostate Cancer, PET/CT Trial in Hefei ([68Ga]Ga-PSMA-D5, [68Ga]Ga-PSMA-11)

Recruiting
  • Prostate Cancer
  • PET/CT
  • Hefei, Anhui, China
    The First Affiliated Hospital of China University of Science and
Jul 19, 2023

TNBC - Triple-Negative Breast Cancer Trial in Brussels (Ga-PSMA PET/CT)

Recruiting
  • TNBC - Triple-Negative Breast Cancer
  • Ga-PSMA PET/CT
  • Brussels, Belgium
    Institut Jules Bordet
Sep 26, 2023

Metastatic Castration-resistant Prostate Cancer (mCRPC) Trial (225Ac-PSMA-R2, 68Ga-PSMA-R2)

Not yet recruiting
  • Metastatic Castration-resistant Prostate Cancer (mCRPC)
  • (no location specified)
Aug 8, 2023

Prostate Cancer, Localized Prostate Carcinoma Trial (PSMA-1007 Positron Emission Tomography (PET) scan)

Not yet recruiting
  • Prostate Cancer
  • Localized Prostate Carcinoma
  • PSMA-1007 Positron Emission Tomography (PET) scan
  • (no location specified)
Aug 14, 2023

Cancer Trial in Meldola, Cesena ([177Lu]Lu-PSMA I&T)

Not yet recruiting
  • Cancer
  • [177Lu]Lu-PSMA I&T
  • Meldola, Forlì, Italy
  • +1 more
May 10, 2023

Metastatic Clear Cell Renal Cell Carcinoma, With Positive PSMA Expression at Tumor Sites Trial (177Lu-PSMA-1

Not yet recruiting
  • Metastatic Clear Cell Renal Cell Carcinoma
  • With Positive PSMA Expression at Tumor Sites
  • 177Lu-PSMA-1 (radiopharmaceutical)
  • (no location specified)
Sep 26, 2023

68Ga-PSMA-11 PET/CT Screening Prior to 177Lu-PSMA-617 Therapy

Enrolling by invitation
  • Castration-Resistant Prostate Carcinoma
  • +2 more
  • Computed Tomography
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 16, 2023

Hepatocellular Carcinoma Trial in Rochester (Gallium Ga 68 Gozetotide, Hepatic Artery Embolization, Positron Emission Tomography

Recruiting
  • Hepatocellular Carcinoma
  • Gallium Ga 68 Gozetotide
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 11, 2023

Metastatic Prostate Cancer Trial in Nanjing (177Lu-PSMA-0057)

Recruiting
  • Metastatic Prostate Cancer
  • Nanjing, Jiangsu, China
    Nanjing First Hospital
Sep 17, 2023

Cancer, Prostate Cancer, Metastatic Cancer Trial (177Lu-PSMA-I&T - escalating renal absorbed dose, 177Lu-PSMA-I&T - recommended

Not yet recruiting
  • Cancer
  • +3 more
  • 177Lu-PSMA-I&T - escalating renal absorbed dose
  • 177Lu-PSMA-I&T - recommended phase 2 regime
  • (no location specified)
Jun 14, 2023

Patients With Metastatic Castration-resistant Prostate Cancer Trial (177Lu-PSMA-617 PET scan)

Not yet recruiting
  • Patients With Metastatic Castration-resistant Prostate Cancer
  • 177Lu-PSMA-617 PET scan
  • (no location specified)
Nov 13, 2023

Prostate Cancer Trial ([177Lu]Lu-PSMA I&T, Stereotactic Radiotherapy)

Not yet recruiting
  • Prostate Cancer
  • [177Lu]Lu-PSMA I&T
  • Stereotactic Radiotherapy
  • (no location specified)
May 30, 2023

Prostatic Tumors, Castration-Resistant Trial in Darlinghurst, Pretoria (225^Ac-PSMA-617, 68^Ga-PSMA-11)

Recruiting
  • Prostatic Neoplasms, Castration-Resistant
  • 225^Ac-PSMA-617
  • 68^Ga-PSMA-11
  • Darlinghurst, Australia
  • +1 more
Nov 23, 2022

Castration-Resistant Prostate Carcinoma, Metastatic Malignant Tumor in the Bone, Stage IVB Prostate Cancer AJCC v8 Trial in San

Not yet recruiting
  • Castration-Resistant Prostate Carcinoma
  • +2 more
  • San Francisco, California
    University of California, San Francisco
Jun 20, 2023

Advanced and/or Metastatic Solid Tumours Trial in Groningen (Radiolabelled CB307, CB307)

Recruiting
  • Advanced and/or Metastatic Solid Tumours
  • Groningen, Netherlands
    University Medical Center Groningen,
Apr 28, 2023

Prostate Cancer, Newly-Diagnosed Prostate Cancer Trial ([18F]PSMA-1007)

Not yet recruiting
  • Prostate Cancer
  • Newly-Diagnosed Prostate Cancer
  • (no location specified)
Nov 3, 2023

Prostate Cancer Trial ([18F]-PSMA-1007)

Not yet recruiting
  • Prostate Cancer
  • [18F]-PSMA-1007
  • (no location specified)
Jan 30, 2023

Castrate Resistant Prostate Cancer, Metastatic Castration-resistant Prostate Cancer, Prostate Cancer Trial in San Francisco

Not yet recruiting
  • Castrate Resistant Prostate Cancer
  • +3 more
  • San Francisco, California
    University of California, San Francisco
Mar 1, 2023

Prostate Cancer Trial (18F-PSMA-1007)

Not yet recruiting
  • Prostate Cancer
  • (no location specified)
Apr 3, 2023

Prostate Adenocarcinoma Trial in Dallas (68-Ga PSMA11)

Not yet recruiting
  • Prostate Adenocarcinoma
  • 68-Ga PSMA11
  • Dallas, Texas
    UT Southwestern Medical Center
Sep 12, 2023

Biochemically Recurrent Prostate Carcinoma Trial in Duarte (Gallium Ga 68-labeled PSMA-11, Positron Emission Tomography)

Suspended
  • Biochemically Recurrent Prostate Carcinoma
  • Gallium Ga 68-labeled PSMA-11
  • Positron Emission Tomography
  • Duarte, California
    City of Hope Medical Center
Oct 12, 2022